Shuttle Pharmaceuticals Holdings OverviewShuttle Pharmaceuticals Holdings Research & Development
Research & Development expenses for SHPH.
Quarterly R&D Expenses
$267240.00
↓ 83.02% YoY
As of Mar 31, 2026
Annual R&D Expenses (TTM)
$2.75M
↓ 40.34% YoY
Trailing 12 months ending Mar 31, 2026